The seven claims bring the total self-substantiated claims submitted to FSANZ for Bimuno GOS to 29.
Clasado Biosciences (Reading, UK) has announced that it has secured seven self-substantiated food-health claims for its galactooligosaccharide (GOS) ingredient, Bimuno GOS, with Food Standards Australia and New Zealand (FSANZ). The seven claims bring the total self-substantiated claims for Bimuno GOS to 29. The claims, submitted in collaboration with Pathway International, an exclusive distributor of the ingredient in Australia and New Zealand, include the following:
The claims, underpinned by scientific studies and clinical trials, can be used on food products containing Bimuno GOS. “The addition of seven new food-health relationship claims with FSANZ represents a significant step forward in our mission to offer the very best in gut health innovation, and a fantastic achievement for our team. Science and substantiated evidence are at the heart of everything we do, and that resonates with today’s consumer needs,” said Lucie Nagy, general counsel for Clasado Biosciences, in a press release. "As the science and regulation around prebiotics develops, there is significant opportunity on the table for health and nutrition brands in supporting gastrointestinal, immune, cognitive and athletic health. And, through the hard work of our regulatory team, formulators can access these claims for their own products."
"The rising recognition of the health advantages and remarkable stability of prebiotic fibres is driving their prominence in new product innovation, and we are delighted to supply Bimuno GOS to formulators across Australia and New Zealand that are seeking a scientifically backed functional core ingredient,” added Wayne Coote, found and managing director of Pathway International.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.